2016 EMA drug approval recommendations

doi:10.1038/nrd.2017.17

PMID: 28148940DOI: 10.1038/nrd.2017.17Feb 6, 2017Paper

2016 EMA drug approval recommendations

Nature Reviews. Drug Discovery

Asher Mullard

Abstract

No abstract listed.

Citations

Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century

Aug 9, 2017·Journal of Drug Targeting·Ruth Duncan

Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

Oct 15, 2019·Frontiers in Genetics·Alireza ShahryariHeiko Lickert

Decision Support Tools for Regenerative Medicine: Systematic Review

Dec 21, 2018·Journal of Medical Internet Research·Ching LamZhanfeng Cui

❮ Previous

Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

2016 EMA drug approval recommendations

Abstract

Citations

Polymer therapeutics at a crossroads? Finding the path for improved translation in the twenty-first century

Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders

Decision Support Tools for Regenerative Medicine: Systematic Review

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Related Papers

A comparison of FDA and EMA drug approval: implications for drug development and cost of care

EMA and national drug agencies: cooperation or competition?

EMA will restrict experts' role in drug assessment if they plan to work for industry

Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice

EMA consults public on plan to increase transparency of drug trial data